Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong
· Delayed Price · Currency is HKD 12.12
+0.44 (3.77%)
Apr 28, 2025, 4:08 PM HKT
Biocytogen Pharmaceuticals (Beijing) Employees
Biocytogen Pharmaceuticals (Beijing) had 1,117 employees as of December 31, 2024. The number of employees increased by 51 or 4.78% compared to the previous year.
Employees
1,117
Change (1Y)
51
Growth (1Y)
4.78%
Revenue / Employee
934.08K HKD
Profits / Employee
31.96K HKD
Market Cap
4.66B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,117 | 51 | 4.78% |
| Dec 31, 2023 | 1,066 | -282 | -20.92% |
| Dec 31, 2022 | 1,348 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BeiGene | 11,000 |
| Hansoh Pharmaceutical Group Company | 8,989 |
| JD Health International | 3,564 |
| WuXi Biologics | 12,575 |
| Innovent Biologics | 5,659 |
| Akeso | 3,035 |
| Alibaba Health Information Technology | 1,435 |
| Sino Biopharmaceutical | 24,379 |
Biocytogen Pharmaceuticals (Beijing) News
- 3 months ago - Biocytogen and Acepodia Join Forces to Advance Bispecific Antibody and Dual-Payload ADCs for Treating Complex Tumors - Financial Post